IQVIA Holdings Inc. (0JDM.L) LSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
IQVIA Holdings Inc.
Address
4820 Emperor boulevard
Durham, NC 27703
United States of America (the)
Phone
919 998 2000
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
93000
First IPO Date
January 29, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Ari Bousbib | Chief Executive Officer & Chairman | 7.16M | 1961 |
| Eric Sherbet | Executive Vice President, General Counsel & Secretary | 1.5M | 1964 |
| Alistair Grenfell | President of Commercial Solutions | 1.7M | 1974 |
| W. Richard Staub | President of Research & Development Solutions | 1.83M | 1963 |
| Michael J. Fedock | Executive Vice President & Chief Financial Officer | 2.21M | 1976 |
| Keriann Cherofsky | Senior Vice President, Corporate Controller & Chief Accounting Officer | 0 | 1985 |
| Duane Sachs | Senior Vice President of Corporate Development | 0 | N/A |
| James G. Berkshire | Executive Vice President of Global Infrastructure & Operations | 0 | 1974 |
| Jeffrey A. Spaeder | Chief Medical & Scientific Officer | 0 | N/A |
| Kerri Joseph | Senior VP of Investor Relations & Treasurer | 0 | N/A |
Description
IQVIA Holdings Inc. is a global leader empowering the life sciences sector with advanced analytics, innovative technology solutions, and comprehensive clinical research services. Operating across the Americas, Europe, Africa, and the Asia-Pacific regions, its capabilities are organized into three main divisions. Within its Technology & Analytics Solutions segment, IQVIA delivers cloud-based applications alongside essential implementation services. It also specializes in real-world solutions, enabling clients to generate and disseminate crucial evidence that informs healthcare decisions and ultimately enhances patient outcomes. This segment extends its expertise to strategic and implementation consulting, encompassing advanced analytics and commercial process outsourcing. Furthermore, it furnishes comprehensive market performance data, tracking pharmaceutical sales, prescribing trends, treatment efficacy, and promotional activities at a granular level – from country-wide views down to regional, zip code, and individual prescriber insights, across diverse channels like retail, hospital, and mail order. The Research & Development Solutions segment offers a broad spectrum of support for clinical trials, from initial strategic planning and design to meticulous project management and clinical monitoring, including innovative virtual trial capabilities. Complementing these, it provides an extensive array of laboratory services, such as central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment focuses on engaging healthcare providers and patients, alongside offering scientific strategy and medical affairs support. IQVIA's client base spans pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. Additionally, the firm maintains a strategic alliance with HealthCore, Inc. Founded in 1982, the company was initially known as Quintiles IMS Holdings, Inc., before rebranding as IQVIA Holdings Inc. in November 2017. Its corporate headquarters are situated in Durham, North Carolina.
